Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runa Speer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Molecular Therapeutics|June 28, 2005
Reverse-phase protein microarrays for tissue-based analysisRuna Speer, Julia D Wulfkuhle, Lance A Liotta, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitutionDaniël M Jonker, Manuela Koch, Per Larsson, et al.
Advances in Experimental Medicine and Biology|July 3, 2008
Molecular network analysis using reverse phase protein microarrays for patient tailored therapyRuna Speer, Julia Wulfkuhle, Virginia Espina, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Proteomic expression profiling of breast cancerHans Neubauer, Tanja Fehm, Christina Schütz, et al.
Cancer Genomics & Proteomics|September 20, 2007
Development of reverse phase protein microarrays for clinical applications and patient-tailored therapyRuna Speer, Julia Wulfkuhle, Virginia Espina, et al.
Anticancer Research|July 22, 2005
Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumorsUdo Jeschke, Anja Bischof, Runa Speer, et al.
American Journal of Obstetrics and Gynecology|November 24, 2022
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trialLueder M Fels, Dustin Costescu, Carolina S Vieira, et al.
Plos One|January 10, 2018
Microbiota-based analysis reveals specific bacterial traits and a novel strategy for the diagnosis of infectious infertilitySimon Graspeuntner, Michael K Bohlmann, Kathrin Gillmann, et al.
Molecular & Cellular Proteomics : MCP|January 27, 2005
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinomaKatherine M Sheehan, Valerie S Calvert, Elaine W Kay, et al.
Journal of Proteome Research|February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapyJulia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Molecular Therapeutics|June 28, 2005
Reverse-phase protein microarrays for tissue-based analysisRuna Speer, Julia D Wulfkuhle, Lance A Liotta, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitutionDaniël M Jonker, Manuela Koch, Per Larsson, et al.
Advances in Experimental Medicine and Biology|July 3, 2008
Molecular network analysis using reverse phase protein microarrays for patient tailored therapyRuna Speer, Julia Wulfkuhle, Virginia Espina, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Proteomic expression profiling of breast cancerHans Neubauer, Tanja Fehm, Christina Schütz, et al.
Cancer Genomics & Proteomics|September 20, 2007
Development of reverse phase protein microarrays for clinical applications and patient-tailored therapyRuna Speer, Julia Wulfkuhle, Virginia Espina, et al.
Anticancer Research|July 22, 2005
Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumorsUdo Jeschke, Anja Bischof, Runa Speer, et al.
American Journal of Obstetrics and Gynecology|November 24, 2022
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trialLueder M Fels, Dustin Costescu, Carolina S Vieira, et al.
Plos One|January 10, 2018
Microbiota-based analysis reveals specific bacterial traits and a novel strategy for the diagnosis of infectious infertilitySimon Graspeuntner, Michael K Bohlmann, Kathrin Gillmann, et al.
Molecular & Cellular Proteomics : MCP|January 27, 2005
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinomaKatherine M Sheehan, Valerie S Calvert, Elaine W Kay, et al.
Journal of Proteome Research|February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapyJulia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
Pageof 2